Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Increases By 10.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 3,200 shares, a growth of 10.3% from the December 31st total of 2,900 shares. Based on an average daily trading volume, of 154,200 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Price Performance

Shares of NASDAQ:BCTXW traded up $0.00 during trading on Monday, hitting $0.17. 363,661 shares of the stock were exchanged, compared to its average volume of 118,248. BriaCell Therapeutics has a 1-year low of $0.11 and a 1-year high of $1.89. The company’s fifty day simple moving average is $0.28 and its 200-day simple moving average is $0.27.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.